According to a recent LinkedIn post from Artera, Atlantic Health has implemented the company’s AI agents to support colonoscopy outreach and preparation. The post describes a program in which automated agents contact patients one week before procedures to confirm appointments, review preparation materials, and respond to questions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights reported early results over a 30‑day period, including 43% of patients successfully answering and confirming their identities and 39% explicitly confirming appointments. The post also cites a 38% reduction in manual call time for staff, suggesting operational efficiencies in administrative workflows.
For investors, the deployment at Atlantic Health may indicate growing acceptance of Artera’s AI‑driven patient engagement tools in clinical settings. If similar metrics can be replicated across additional health systems, the approach could support revenue growth through expanded adoption and strengthen Artera’s positioning in the healthcare AI and workflow automation market.
The post further implies that improved execution in screening outreach could help close care gaps in high‑impact areas such as colorectal cancer detection. Greater integration into preventive care pathways could deepen relationships with health system customers, potentially increasing switching costs and supporting longer‑term contract opportunities for Artera.